Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Surgalign Holdings, Inc. SRGA
$1.03
-$0.04 (-3.50%)
На 18:02, 12 мая 2023
+239.81%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
8828526.00000000
-
week52high
6.77
-
week52low
0.99
-
Revenue
81979000
-
P/E TTM
0
-
Beta
1.80726600
-
EPS
-9.05000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 10:59
Описание компании
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Craig-Hallum | Hold | Buy | 28 сент 2021 г. |
BTIG | Buy | 03 февр 2021 г. | |
Piper Sandler | Overweight | 02 февр 2021 г. | |
JMP Securities | Market Outperform | Market Outperform | 26 окт 2020 г. |
HC Wainwright & Co. | Buy | 21 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Rich Terry M. | D | 160176 | 190 | 13 янв 2023 г. |
Rich Terry M. | D | 160366 | 121 | 31 дек 2022 г. |
Rich Terry M. | D | 160487 | 458 | 07 ноя 2022 г. |
Sangiorgio Enrico | D | 32090 | 106 | 07 ноя 2022 г. |
Amoruso Paolo | A | 31000 | 27000 | 01 сент 2022 г. |
Durall William Scott | A | 64513 | 34416 | 15 авг 2022 г. |
Sangiorgio Enrico | A | 32196 | 26395 | 15 авг 2022 г. |
Thunander Christopher | A | 28360 | 15666 | 15 авг 2022 г. |
Rich Terry M. | A | 160945 | 52380 | 15 авг 2022 г. |
Mackey Marc E. | A | 48869 | 30952 | 15 авг 2022 г. |
Новостная лента
Surgalign Holdings, Inc. (SRGA) Q3 2022 Earnings Call Transcript
Seeking Alpha
02 ноя 2022 г. в 21:20
Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Terry Rich - Chief Executive Officer David Lyle - Chief Financial Officer Chris Thunander - Chief Accounting Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Operator Greetings, and welcome to the Surgalign Holdings 2022 Third Quarter Earnings Call. It is now my pleasure to introduce your host, David Lyle.
Surgalign Schedules Third Quarter 2022 Earnings Release for November 2, 2022
GlobeNewsWire
25 окт 2022 г. в 08:30
DEERFIELD, Ill., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced its plans to release financial results for its third quarter ended September 30, 2022 after the close of trading on November 2, 2022.
Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
09 авг 2022 г. в 22:29
Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q2 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants David Lyle - Chief Financial Officer Terry Rich - President and Chief Executive Officer Chris Thunander - Chief Accounting Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Operator Good day ladies and gentlemen and welcome to the Surgalign Holdings, Incorporated Second Quarter 2022 Results Conference Call. All lines have been placed in a listen only mode and the floor will be open for your questions and comments following the presentation.
Here's Why Surgalign Holdings Shares Are Falling Today
Benzinga
16 мая 2022 г. в 12:10
Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower by 19.73% at $0.15 after the company announced a 1-for-30 reverse stock split. The 1-for-30 reverse stock split will take effect at the opening of trading on the Nasdaq Global Select Market on Tuesday.
Surgalign Holdings' (SRGA) CEO Terry Rich on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
10 мая 2022 г. в 20:56
Surgalign Holdings, Inc. (NASDAQ:SRGA ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants David Lyle – Chief Financial Officer Terry Rich – President and Chief Executive Officer Chris Thunander – Chief Accounting Officer Conference Call Participants Brooks O'Neil – Lake Street Capital Matt Hewitt – Craig-Hallum Operator Greetings, and welcome to the Surgalign Holdings, Incorporated First Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.